Diana Camargo
Optometrist · Fort Lauderdale, FLNPI 1811141286
Payments from drug & device makers
Across 123 payments — averaging $25.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$597
- Alcon$358
- Bausch & Lomb Americas Inc.$349
- Tarsus Pharmaceuticals, Inc.$342
- Johnson & Johnson Vision Care, Inc.$311
- Novartis$222
- plus $925 from 14 others
What the payments were for
- Food & beverage$3,08899%
- Gifts$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $597 |
| Alcon | 12 | $358 |
| Bausch & Lomb Americas Inc. | 15 | $349 |
| Tarsus Pharmaceuticals, Inc. | 21 | $342 |
| Johnson & Johnson Vision Care, Inc. | 3 | $311 |
| Novartis | 13 | $222 |
| Thea Pharma Inc. | 10 | $211 |
| Sun Pharmaceutical Industries Inc. | 2 | $148 |
| Harrow Eye, LLC | 3 | $113 |
| Aerie Pharmaceuticals, Inc. | 6 | $111 |
| NEW World Medical,inc. | 1 | $84 |
| Oyster Point Pharma, Inc. | 3 | $66 |
| Coopervision Inc. | 2 | $46 |
| Dompe US, Inc. | 1 | $34 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $31 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $20 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
| Eyevance Pharmaceuticals LLC | 1 | $12 |
| Quidel Corporation | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,105 in reported general payments places this provider in the 80th percentile of 3,166 optometrist providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 55 | $39,266 |
| XiidraLifitegrast | 15 | $10,337 |
| Prednisolone Acetate | 17 | $407 |
| Latanoprost | 20 | $118 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $597 | $39,26655 claims |
| Bausch & Lomb Americas Inc.Xiidra | $349 | $10,33715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,166 optometrist providers in Florida.
Other optometrist in Fort Lauderdale
- Scott SchecterFort Lauderdale$436K
- Julie RodmanFort Lauderdale$205K
- Michael KynnJacksonville$4.5M
- Christine HalodaJacksonville$3.1M
- Bradley GieddWinter Park$2.5M
- Christopher PearsonLongwood$2.5M
- Mark PerryOrlando$1.6M
- Bryan StamJacksonville Beach$1M
- Oksana SovaJacksonville$841K
- James HoffmanOrange Park$795K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.